title: [Influence of pravastatin therapy on expression of P-selectin].
abstract: OBJECTIVE
  To study the mechanism of pravastatin enhancing atherosclerosis regression.
  
  
  METHODS
  Patients with hypercholesterolemia were treated with pravastatin 10-20 mg/d for 4 and 8 weeks. The changes of blood cholesterol and platelet functions were examined.
  
  
  RESULTS
  After 4 weeks and 8 weeks treatment, the expression of platelet membrane P-selectin was decreased from 748 +/- 154 molecular number(MN)/platelet to 478 +/- 110 MN/platelet and 378 +/- 119 MN/platelet, respectively, plasma P-selectin was decreased from 24.3 +/- 9.9 micrograms/L to 16.8 +/- 4.5 and 16.1 +/- 4.0 micrograms/L, respectively, correlative with the lowering of blood cholesterol. Platelet P-selectin was positively correlated with plasma P-selectin(r = 0.8722).
  
  
  CONCLUSIONS
  The early benefit of pravastatin in enhancing atherosclerosis regression was partly due to the improvement of platelet function.
authors.affiliation: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Medical University, Guangzhou 510120.
authors.forename: S
authors.initials: S
authors.lastname: Yin
authors.forename: L
authors.initials: L
authors.lastname: Ma
authors.forename: L
authors.initials: L
authors.lastname: Xu
mesh_terms: D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000096:biosynthesis; D010974:Platelet Aggregation / Q000187:drug effects; D017035:Pravastatin / Q000627:therapeutic use*
chemical_list: D019007:P-Selectin; D017035:Pravastatin